UPS Healthcare: We’re investing to support our customer’s breakthrough therapies
UPS Healthcare has announced the expansion of its specialised temperature-controlled fleet across Emilia-Romagna, Toscana, Veneto, Friuli-Venezia-Giulia, and Trentino-Alto-Adige.
Previously covering Sicilia, Calabria, Lombardia and Liguria, the expanded fleet now covers 60% of Italy with a dedicated pharmaceutical transport network, providing an end-to-end service that can meet the evolving needs of the next generation of healthcare shipments.
“We’re investing to support our customer’s breakthrough therapies, which are among the most complex and sensitive medical treatments ever,” said Fabio Mioli, Managing Director, South Europe UPS Healthcare. “These critical treatments demand near-perfect levels of service, and our expanded fleet will play a vital role in offering a quality end-to-end service that ensures these treatments arrive at the right time and the right temperature.”
The vehicles are capable of supporting transport healthcare products in temperature-controlled environments and offer next-day, GDP-compliant delivery for hospitals, pharmacies, clinics, laboratories, and doctors that are all increasingly relying on time-critical and temperature-sensitive treatments for their patients. This expansion adds to UPS Healthcare’s existing cold chain transport services in Belgium, the Netherlands, Luxembourg, Hungary, the UK and Poland.
Innovations in biologics, specialty pharmaceuticals and personalized medicine demand precision, temperature-controlled logistics to deliver patient-critical products, which are especially important for the Italian market that manufactures many of the world’s most important sterile pharmaceuticals.
This expansion is part of UPS Healthcare’s continued investment in Italy, including the recent launch of UPS Premier, a service that can prioritize and track critical shipments within 3 meters of their location anywhere in UPS’s global network.
This is in addition to an upcoming, new 40,000 square meter built-to-suit healthcare logistics facility in Rome. The state-of-the-art GMP-compliant facility will include multiple controlled temperature environments for healthcare products requiring -20C to -80C, 2C to 8C and 15C to 25C storage.
In 2021, UPS Healthcare invested in over 36,000m2 of cold chain storage and freezer capacity globally, including in newly dedicated and upgraded healthcare facilities in Poland, the Czech Republic, Germany, the Netherlands, and Italy. These facilities add to the existing 1 million m2 of dedicated healthcare warehousing across 134 strategically located GDP/GMP compliant facilities in 30 countries.